Ignite Creation Date:
2025-12-24 @ 4:45 PM
Ignite Modification Date:
2025-12-28 @ 6:25 PM
Study NCT ID:
NCT04698850
Status:
WITHDRAWN
Last Update Posted:
2022-08-10
First Post:
2021-01-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Brolucizumab vs. Aflibercept for Retinal Angiomatous Proliferation
Sponsor:
Faculty Hospital Kralovske Vinohrady
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
BEY-RAP V1.0
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None